StreetAccount Summary: Stocks reaching new 52-week highs/lows (93 total)
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (65 total)
StreetAccount Summary: Notable Drug Events expected for the week of 19-Oct
StreetAccount Summary: Stocks reaching new 52-week highs/lows (200 total)
argenx to present data on VYVGART, empasiprubart from 29-Oct through 1-Nov ($812.95, 0.00)
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (49 total)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (202 total)
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (81 total)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (187 total)
Powered by FactSet Research Systems Inc.